These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation. Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347 [TBL] [Abstract][Full Text] [Related]
43. Role of lysosomal cathepsins in naphthazarin- and Fas-induced apoptosis in oral squamous cell carcinoma cells. Johansson AC; Norberg-Spaak L; Roberg K Acta Otolaryngol; 2006 Jan; 126(1):70-81. PubMed ID: 16308258 [TBL] [Abstract][Full Text] [Related]
44. Silica-induced apoptosis in mouse alveolar macrophages is initiated by lysosomal enzyme activity. Thibodeau MS; Giardina C; Knecht DA; Helble J; Hubbard AK Toxicol Sci; 2004 Jul; 80(1):34-48. PubMed ID: 15056807 [TBL] [Abstract][Full Text] [Related]
46. Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Heinrich M; Neumeyer J; Jakob M; Hallas C; Tchikov V; Winoto-Morbach S; Wickel M; Schneider-Brachert W; Trauzold A; Hethke A; Schütze S Cell Death Differ; 2004 May; 11(5):550-63. PubMed ID: 14739942 [TBL] [Abstract][Full Text] [Related]
47. Processing of human cathepsin D is independent of its catalytic function and auto-activation: involvement of cathepsins L and B. Laurent-Matha V; Derocq D; Prébois C; Katunuma N; Liaudet-Coopman E J Biochem; 2006 Mar; 139(3):363-71. PubMed ID: 16567401 [TBL] [Abstract][Full Text] [Related]
48. Cathepsin D in cancer metastasis: a protease and a ligand. Rochefort H; Liaudet-Coopman E APMIS; 1999 Jan; 107(1):86-95. PubMed ID: 10190284 [TBL] [Abstract][Full Text] [Related]
49. Cytosol cathepsin-D content and proliferative activity of human breast cancer. The Comitato Italiano per il Controllo di Qualita del Laboratorio in Oncologia. Paradiso A; Mangia A; Correale M; Abbate I; Ferri G; Piffanelli A; Catozzi L; Amadori D; Riccobon A; De Lena M Breast Cancer Res Treat; 1992; 23(1-2):63-70. PubMed ID: 1446053 [TBL] [Abstract][Full Text] [Related]
50. Cyanobacterial peptides as a prototype for the design of cathepsin D inhibitors. Xu H; Bao K; Tang S; Ai J; Hu H; Zhang W J Pept Sci; 2017 Sep; 23(9):701-706. PubMed ID: 28585417 [TBL] [Abstract][Full Text] [Related]
51. Cathepsin D is partly endocytosed by the LRP1 receptor and inhibits LRP1-regulated intramembrane proteolysis. Derocq D; Prébois C; Beaujouin M; Laurent-Matha V; Pattingre S; Smith GK; Liaudet-Coopman E Oncogene; 2012 Jun; 31(26):3202-12. PubMed ID: 22081071 [TBL] [Abstract][Full Text] [Related]
52. Pro-cathepsin D interacts with the extracellular domain of the beta chain of LRP1 and promotes LRP1-dependent fibroblast outgrowth. Beaujouin M; Prébois C; Derocq D; Laurent-Matha V; Masson O; Pattingre S; Coopman P; Bettache N; Grossfield J; Hollingsworth RE; Zhang H; Yao Z; Hyman BT; van der Geer P; Smith GK; Liaudet-Coopman E J Cell Sci; 2010 Oct; 123(Pt 19):3336-46. PubMed ID: 20826454 [TBL] [Abstract][Full Text] [Related]
53. Leukocyte Elastase Inhibitor, the precursor of L-DNase II, inhibits apoptosis by interfering with caspase-8 activation. Padrón-Barthe L; Courta J; Leprêtre C; Nagbou A; Torriglia A Biochim Biophys Acta; 2008 Oct; 1783(10):1755-66. PubMed ID: 18674571 [TBL] [Abstract][Full Text] [Related]
54. Design, synthesis, and bioactivities of tasiamide B derivatives as cathepsin D inhibitors. Li Z; Bao K; Xu H; Wu P; Li W; Liu J; Zhang W J Pept Sci; 2019 Apr; 25(4):e3154. PubMed ID: 30734395 [TBL] [Abstract][Full Text] [Related]
55. Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: correlation with cytosolic assay. Roger P; Montcourrier P; Maudelonde T; Brouillet JP; Pages A; Laffargue F; Rochefort H Hum Pathol; 1994 Sep; 25(9):863-71. PubMed ID: 8088760 [TBL] [Abstract][Full Text] [Related]
57. Cathepsin H: Molecular characteristics and clues to function and mechanism. Wang Y; Zhao J; Gu Y; Wang H; Jiang M; Zhao S; Qing H; Ni J Biochem Pharmacol; 2023 Jun; 212():115585. PubMed ID: 37148981 [TBL] [Abstract][Full Text] [Related]
58. Alterations and role of human cathepsin D in cancer metastasis. Rochefort H; Liaudet E; Garcia M Enzyme Protein; 1996; 49(1-3):106-16. PubMed ID: 8797001 [TBL] [Abstract][Full Text] [Related]
59. Cathepsin D primes caspase-8 activation by multiple intra-chain proteolysis. Conus S; Pop C; Snipas SJ; Salvesen GS; Simon HU J Biol Chem; 2012 Jun; 287(25):21142-51. PubMed ID: 22528489 [TBL] [Abstract][Full Text] [Related]
60. Cathepsin D as a Promising Target for the Discovery of Novel Anticancer Agents. Dubey V; Luqman S Curr Cancer Drug Targets; 2017; 17(5):404-422. PubMed ID: 28215160 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]